The study analyzed the expression of lncRNA MALAT1 and NLRP3 in lower limb atherosclerotic disease in diabetes patients, explored the relationship between them and the disease, and whether lncRNA MALAT1 may be a new biomarker of LEAD. This evidence concerns the gene MALAT1 and diabetes mellitus.